Hospital-free days in the first year after lung transplantation and subsequent survival
Reda E. Girgis,
Austin Frisch,
Cameron K. Lawson,
Benjamin Kowalske,
Lindsey LeQuia,
Ryan J. Hadley,
Sheila Krishnan,
Gayathri Sathiyamoorthy,
Edward T. Murphy
Affiliations
Reda E. Girgis
Corresponding author: Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, MI.; Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Austin Frisch
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Cameron K. Lawson
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Benjamin Kowalske
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Lindsey LeQuia
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Ryan J. Hadley
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Sheila Krishnan
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Gayathri Sathiyamoorthy
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Edward T. Murphy
Richard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan
Background: Complications occurring during the first postoperative year after lung transplantation increase the risk of long-term mortality. These events often lead to prolonged and repeated hospitalizations. We sought to assess the relationship between days outside the hospital or hospital-free days (HFD) during the first post-transplant year among 1-year survivors and subsequent retransplant-free survival. Methods: In a single-center study, we derived total inpatient days (initial transplant episode, readmission, and emergency room/observation) from the electronic medical record of lung transplant recipients who survived 1 year. The cohort was divided into HFD quartiles and Kaplan-Meier curves of subsequent transplant-free survival were compared with log-rank analysis. A Cox proportional hazards model was used to test the association of HFD with outcome and adjusted for selected variables. Results: Among 238 patients, 42 deaths and 2 retransplants occurred after a median of 3.6 years post-transplant. The median HFD was 341 (interquartile range: 324, 348). Estimated transplant-free survival at 3 and 5 years post-transplant in the lowest quartile of HFD (79% and 56%, respectively) was considerably worse compared with the first quartile (98% and 94%; p < 0.01). Fewer HFD were associated with subsequent death or retransplant [hazard ratio: 0.90 (95% confidence interval: 0.85, 0.94; p < 0.001) for each 10-day increase] and remained significant after adjusting for several potentially confounding variables. Conclusions: HFD during the first year after lung transplantation is a predictor of subsequent long-term outcomes and may be a useful surrogate marker for clinical trials during the early postoperative period.